Carlo Di Pietrantonj
Overview
Explore the profile of Carlo Di Pietrantonj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Pietrantonj C, Rivetti A, Marchione P, Debalini M, Demicheli V
Cochrane Database Syst Rev
. 2021 Nov;
11:CD004407.
PMID: 34806766
Background: Measles, mumps, rubella, and varicella (chickenpox) are serious diseases that can lead to serious complications, disability, and death. However, public debate over the safety of the trivalent MMR vaccine...
2.
Giraudo M, Falcone M, Cadum E, Deandrea S, Scondotto S, Mattaliano A, et al.
Epidemiol Prev
. 2021 Jan;
44(5-6 Suppl 2):42-50.
PMID: 33412793
The article compares two of the most followed indices in the monitoring of COVID-19 epidemic cases: the Rt and the RDt indices. The first was disseminated by the Italian National...
3.
Di Pietrantonj C, Rivetti A, Marchione P, Debalini M, Demicheli V
Cochrane Database Syst Rev
. 2020 Apr;
4:CD004407.
PMID: 32309885
Background: Measles, mumps, rubella, and varicella (chickenpox) are serious diseases that can lead to serious complications, disability, and death. However, public debate over the safety of the trivalent MMR vaccine...
4.
Bidone S, Baldina V, Di Pietrantonj C
Assist Inferm Ric
. 2019 Dec;
38(4):165-173.
PMID: 31834301
Introduction: Mobile phones are often used in the operating theatres, with possible health risks for patients. Phone surfaces can be contaminated with pathogens causing infections (infectious risk). In addition, mobile...
5.
Jagannath V, Filippini G, Di Pietrantonj C, Asokan G, Robak E, Whamond L, et al.
Cochrane Database Syst Rev
. 2018 Sep;
9:CD008422.
PMID: 30246874
Background: This review is an update of a previously published review, "Vitamin D for the management of multiple sclerosis" (published in the Cochrane Library; 2010, Issue 12). Multiple sclerosis (MS)...
6.
Vairo F, Di Pietrantonj C, Pasqualini C, Mammone A, Lanini S, Nicastri E, et al.
Viruses
. 2018 Sep;
10(9).
PMID: 30223536
CHIKV has become an emerging public health concern in the temperate regions of the Northern Hemisphere as a consequenceof the expansion of the endemic areas of its vectors (mainly and...
7.
Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas R, et al.
Cochrane Database Syst Rev
. 2018 Feb;
2:CD004876.
PMID: 29388197
Background: The consequences of influenza in the elderly (those age 65 years or older) are complications, hospitalisations, and death. The primary goal of influenza vaccination in the elderly is to...
8.
Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C
Cochrane Database Syst Rev
. 2018 Feb;
2:CD001269.
PMID: 29388196
Background: The consequences of influenza in adults are mainly time off work. Vaccination of pregnant women is recommended internationally. This is an update of a review published in 2014. Future...
9.
Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V
Cochrane Database Syst Rev
. 2018 Feb;
2:CD004879.
PMID: 29388195
Background: The consequences of influenza in children and adults are mainly absenteeism from school and work. However, the risk of complications is greatest in children and people over 65 years...
10.
La Mantia L, Di Pietrantonj C, Rovaris M, Rigon G, Frau S, Berardo F, et al.
Cochrane Database Syst Rev
. 2016 Nov;
11:CD009333.
PMID: 27880972
Background: Interferons-beta (IFNs-beta) and glatiramer acetate (GA) were the first two disease-modifying therapies (DMTs) approved 20 years ago for the treatment of multiple sclerosis (MS). DMTs' prescription rates as first...